188 related articles for article (PubMed ID: 28562634)
21. Co-expression profiling of plasma miRNAs and long noncoding RNAs in gastric cancer patients.
Ghaedi H; Mozaffari MAN; Salehi Z; Ghasemi H; Zadian SS; Alipoor S; Hadianpour S; Alipoor B
Gene; 2019 Mar; 687():135-142. PubMed ID: 30447342
[TBL] [Abstract][Full Text] [Related]
22. Associations between serum CA724 and HER2 overexpression among stage II-III resectable gastric cancer patients: an observational study.
Chen XZ; Zhang WH; Chen HN; Liu JP; He D; Liu Y; Liu K; Chen XL; Mo XM; Zhou ZG; Hu JK
Oncotarget; 2016 Apr; 7(17):23647-57. PubMed ID: 27027339
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-421 is a new potential diagnosis biomarker with higher sensitivity and specificity than carcinoembryonic antigen and cancer antigen 125 in gastric cancer.
Wu J; Li G; Yao Y; Wang Z; Sun W; Wang J
Biomarkers; 2015 Feb; 20(1):58-63. PubMed ID: 25510566
[TBL] [Abstract][Full Text] [Related]
24. Autoantibody against 14-3-3 zeta: a serological marker in detection of gastric cancer.
Qin J; Wang S; Wang P; Wang X; Ye H; Song C; Dai L; Wang K; Jiang B; Zhang J
J Cancer Res Clin Oncol; 2019 May; 145(5):1253-1262. PubMed ID: 30887154
[TBL] [Abstract][Full Text] [Related]
25. Circulating microRNAs in plasma of patients with gastric cancers.
Tsujiura M; Ichikawa D; Komatsu S; Shiozaki A; Takeshita H; Kosuga T; Konishi H; Morimura R; Deguchi K; Fujiwara H; Okamoto K; Otsuji E
Br J Cancer; 2010 Mar; 102(7):1174-9. PubMed ID: 20234369
[TBL] [Abstract][Full Text] [Related]
26. [Expression and differential diagnostic value of serum microRNA for invasive pulmonary aspergillosis].
Wen ZN; Ling ZG; Huang Y; Li X
Zhonghua Jie He He Hu Xi Za Zhi; 2017 Apr; 40(4):272-277. PubMed ID: 28395406
[No Abstract] [Full Text] [Related]
27. Downregulation of serum miR-17 and miR-106b levels in gastric cancer and benign gastric diseases.
Zeng Q; Jin C; Chen W; Xia F; Wang Q; Fan F; Du J; Guo Y; Lin C; Yang K; Li J; Peng X; Li X; Cao K
Chin J Cancer Res; 2014 Dec; 26(6):711-6. PubMed ID: 25561770
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic significance of soluble human leukocyte antigen-G for gastric cancer.
Pan YQ; Ruan YY; Peng JB; Han QY; Zhang X; Lin A; Yan WH
Hum Immunol; 2016 Apr; 77(4):317-24. PubMed ID: 26788811
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA biomarkers in whole blood for detection of pancreatic cancer.
Schultz NA; Dehlendorff C; Jensen BV; Bjerregaard JK; Nielsen KR; Bojesen SE; Calatayud D; Nielsen SE; Yilmaz M; Holländer NH; Andersen KK; Johansen JS
JAMA; 2014 Jan 22-29; 311(4):392-404. PubMed ID: 24449318
[TBL] [Abstract][Full Text] [Related]
30. Serum miR-126 level combined with multi- detector computed tomography in the preoperative prediction of lymph node metastasis of gastric cancer.
Feng R; Lu S; Sah BK; Beeharry MK; Zhang H; Yan M; Liu B; Li C; Zhu Z
Cancer Biomark; 2018; 22(4):773-780. PubMed ID: 29843221
[TBL] [Abstract][Full Text] [Related]
31. Urinary cell-free microRNA-106b as a novel biomarker for detection of bladder cancer.
Zhou X; Zhang X; Yang Y; Li Z; Du L; Dong Z; Qu A; Jiang X; Li P; Wang C
Med Oncol; 2014 Oct; 31(10):197. PubMed ID: 25168920
[TBL] [Abstract][Full Text] [Related]
32. Upregulation of microRNA 181c expression in gastric cancer tissues and plasma.
Cui MH; Hou XL; Lei XY; Mu FH; Yang GB; Yue L; Fu Y; Yi GX
Asian Pac J Cancer Prev; 2013; 14(5):3063-6. PubMed ID: 23803080
[TBL] [Abstract][Full Text] [Related]
33. Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma.
Shi BM; Lu W; Ji K; Wang YF; Xiao S; Wang XY
World J Gastroenterol; 2017 May; 23(20):3713-3720. PubMed ID: 28611524
[TBL] [Abstract][Full Text] [Related]
34. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer.
Wang N; Wang L; Yang Y; Gong L; Xiao B; Liu X
Biochem Biophys Res Commun; 2017 Nov; 493(3):1322-1328. PubMed ID: 28986250
[TBL] [Abstract][Full Text] [Related]
35. Plasma miR-122 and miR-192 as potential novel biomarkers for the early detection of distant metastasis of gastric cancer.
Chen Q; Ge X; Zhang Y; Xia H; Yuan D; Tang Q; Chen L; Pang X; Leng W; Bi F
Oncol Rep; 2014 Apr; 31(4):1863-70. PubMed ID: 24481716
[TBL] [Abstract][Full Text] [Related]
36. Serum microRNA-381: A Potential Marker for Early Diagnosis of Gastric Cancer.
Li Y; Sun H; Guan J; Ji T; Wang X
Yonsei Med J; 2019 Aug; 60(8):720-726. PubMed ID: 31347326
[TBL] [Abstract][Full Text] [Related]
37. Carcinoembryonic antigen, carbohydrate antigen 199 and carbohydrate antigen 724 in gastric cancer and their relationship with clinical prognosis.
Wang R; Zuo CL; Zhang R; Zhu LM
World J Gastrointest Oncol; 2023 Aug; 15(8):1475-1485. PubMed ID: 37663935
[TBL] [Abstract][Full Text] [Related]
38. Clinical value of combined tests for tumor markers for gastric cancer.
Xu MX; Cui HJ; Yao TL; Gui YF
J Biol Regul Homeost Agents; 2018; 32(2):263-268. PubMed ID: 29685004
[TBL] [Abstract][Full Text] [Related]
39. Serum microRNA panel excavated by machine learning as a potential biomarker for the detection of gastric cancer.
Huang Y; Zhu J; Li W; Zhang Z; Xiong P; Wang H; Zhang J
Oncol Rep; 2018 Mar; 39(3):1338-1346. PubMed ID: 29286167
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
